New Zealand joins growing list of nations restricting puberty-blocking drugs for minors New Zealand has banned puberty-blocking drugs for minors with gender dysphoria, following similar restrictions in the U.K., Finland, Sweden and Norway due to concerns over long-term safety and efficacy. The ban follows an evidence review highlighting irreversible side effects, including stunted bone growth, infertility, cognitive impairment and increased risks of cardiovascular disease, diabetes and cancer. Health Minister Simeon Brown stated the government is taking a cautious stance pending further research, allowing current patients to continue treatment while awaiting results from a major U.K. study expected in 2031. The decision aligns…

Newswire

Features

The Latest